Sentences with phrase «report continued growth»

Frankfurt, 7 March 2017 — The Literary Agents & Scouts Centre at the Frankfurter Buchmesse reports continued growth, already being sold out for October: 301 agents (300 in 2016) have booked 480 tables (460 in 2016).
Eurostar has reported continued growth in both passenger numbers and sales revenues during the third quarter of 2013.

Not exact matches

Even after a return to (low) growth, Yahoo will continue losing share of the worldwide search market as other players — including Google, Baidu, Microsoft and Sohu — grow their search ad businesses more quickly,» the market research firm reported Monday.
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
And the growth continues: Amazon's Seattle footprint of 8.1 million square feet is expected to soar to more than 12 million square feet within five years,» The Seattle Times reported in August 2017.
«The continued growth in share augers well for Pandora as the company looks to extend its reach into local radio advertising markets,» he wrote in a May 6 report.
Josh Baribeau, a Canaccord Capital analyst, wrote in his initiation report that the «solar market will continue to experience rapid growth as the U.S., Japan, China, and emerging markets drive more adoption of clean, renewable energy.»
WASHINGTON, April 18 - «Robust» business borrowing, rising consumer spending, and tight labor markets indicate the U.S. economy remains on track for continued growth, the Federal Reserve reported on Wednesday, with the risks of a global trade war the one big outlier.
CNBC reported on Wednesday that the company would lay off about 100 engineers, just weeks after CEO Evan Spiegel said the company's recent headcount growth would continue.
Its snack division, Frito - Lay North America, continues to grow, with the unit reporting sales growth of 3 percent.
Nike reported earnings that beat analysts» expectations, fueled by international growth and continued momentum within China.
Starbucks (sbux) remains a stronger performer in the sector, continuing to report growth as existing stores in the U.S. while also continuing to expand.
Two weeks later, comScore's monthly report on U.S. smartphone market share showed a 4 % uptick in May for Google's Android platform, with every indication of continued growth.
«While we see a potential drop in total number of U.S. jobs created in 2017, as reported by Kiplinger, as well as an overall expected drop in GDP growth, the cannabis industry continues to be a positive contributing factor to growth at a time of potential decline,» says De Carcer in a statement.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
I will also share dividend growth stock ideas and... Continue reading Q3 - 2017 Dividend — The Dividend Report
A continued search for yield has «fueled rampant asset price growth elsewhere,» the report explains.
The publisher of Europe's top - selling daily Bild on Wednesday reported a slowdown in its core profit growth as a continued decline in print circulation weighed.
Following the better - than - expected September jobs report, several economic analyses have pointed out the continuing lack of meaningful wage growth, even as tens of thousands of people head back to work.
I will also share dividend growth stock ideas and... Continue reading Q3 - 2016 Dividend Report
Wall Street got exactly what it wanted from Friday's jobs report: solid hiring, moderate wage growth and continued low unemployment.
Snap Inc. reported a massive loss and a continued slowdown in user growth, while revenue fell below Wall Street's expectations in its first quarterly earnings as a public company.
Revised estimates for 2014 healthcare spending growth show increases larger than initially reported — which continues a worrisome trend, says a new C.D. Howe Institute report.
By the numbers, ForeScout reported revenue of $ 166.8 million in 2016, up from $ 126 million in 2015, showing continued growth with revenue of $ 90.6 million for the first six months of 2017.
The report outlines barriers to the growth and adoption of financial technology (FinTech) in Canada and provides a number of recommendations to help regulators and policymakers continue to promote FinTech innovation.
«Overall, a report showing strong job growth, a falling unemployment rate, and steady wage gains should be mildly hawkish for markets and supportive of continued but gradual Fed rate hikes, keeping a June hike well priced above 90 per cent,» TD said.
Data provided represents a compilation of information from leading private company financial research... Continue reading GrowthCap's Growth Equity Valuation Report: B2B Software →
The International segment reported a loss from continuing operations before income taxes of $ 1.3 million on a US GAAP basis and an underlying pretax loss of $ 1.0 million in the fourth quarter, versus a loss of $ 5.1 million for both measures a year ago, driven by the addition of the Miller brands, volume growth and positive pricing in Latin America and Australia, cost savings in MG&A, and cycling the substantial restructure of our China business in 2015.
Amazon.com Inc. (NASDAQ: AMZN) reported an impressive first quarter Thursday, reinforcing sell - side optimism in the company's ability to drive continued growth across multiple segments.
In the Bank's last Monetary Policy Report (MPR) in October, we forecast that the Canadian economy would return to positive growth in the second half of this year, and that annual growth would continue to increase in 2016 and 2017.
Liquidspace's Q4, 2017 U.S. Flexible Office Report covers the continued growth of coworking and other forms of flexible offices.
The Canadian economy continues to face serious macroeconomic challenges, the most important of which is addressing the burden of a slow - growth recovery, according to a report from the C.D. Howe...
With our same - restaurant sales assumptions, new unit — our new restaurant unit growth plans and cost expectations, we anticipate that reported diluted net earnings per share growth from continuing operations for fiscal 2013 will be between 8 % and 12 % compared to our reported diluted net earnings per share from continuing operations of $ 3.58 in fiscal 2012.
The Biz2Credit Small Business Lending Index also reported that approval rates by credit unions and alternative lenders were relatively unchanged, while institutional lenders continued slow but steady growth in approval percentage.
Coming into Tuesday's fourth - quarter financial report, Johnson & Johnson shareholders were ready to see a tax reform hit but wanted continued growth in revenue and earnings.
Last Friday's strong jobs report, combined with continued steady growth in gross domestic product, offers the Federal Reserve all the ammunition it needs to start raising rates at its June meeting — which we believe it should do — meaning the need for flexibility has never been greater.
To that point, Ford's December report of its iconic F - Series truck line continues to signal positive growth in the U.S. economy.
Transactions continued to pick up, marking the 10th consecutive month in which some degree of improvement has been reported and rising sales expectations during November suggest stronger growth may be on the horizon.
As more companies reported «beat and lower» earnings, market expectations continued to fall to the point where third quarter index earnings growth is now expected to be half of what was forecast in June.
Employment continued to grow at a modest pace, with most districts reporting labor shortages, which were said to constrain growth in some cases, the report said.
As this continues, I think that we will see more positive earnings reports and more growth in the value of the stock moving forward.
«As attention and interest in the blockchain space as a whole continues to hit new highs, we are entering a new phase in the industry's growth: the phase where we are finally going from experiments and tests to real, live applications,» according to Ethereum's Q4 report.
We believe that Facebook's normalized operating margin is substantially higher than what it reports, as the company continues to invest heavily in a variety of growth initiatives.
Recent reports, including surprisingly robust February job growth, indicate the recovery is continuing at least at the pace it was in December when the Fed announced it would gradually scale back its monthly $ 85 billion in bond purchases.
Capacity constraints on production growth continue to be reported, with firms highlighting shortages of materials, equipment and transport and distribution services.
As the report's authors pointed out, strong demand continues to drive price growth in the Austin real estate market.
As earnings season ramps into full gear, the performance of some of the biggest names could determine future of the tech boomAs large tech companies report first - quarter earnings in a flood of results during the next two weeks, they face a major test: Will they continue to post huge growth, and fuel further overall gains for the market, or settle into a more mild adulthood?
Greetings, The United States: The SMI report continues to show healthy economic growth for the US in February.
The eurozone's lack of organic growth and its reliance on continued central bank stimulus likely increased market sensitivity to a report claiming the ECB might be considering tapering its $ 80 billion monthly purchases of bonds, though the claim was quickly dismissed by the ECB.
What to watch for: Analysts expect Facebook to report a solid quarter for growth, profitability and engagement trends, especially as the company continues to improve its desktop and mobile advertising offerings, said MKM Partners analyst Rob Sanderson.
a b c d e f g h i j k l m n o p q r s t u v w x y z